摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-chloro-10H-phenothiazin-10-yl)propan-1-amine hydrochloride | 3763-80-2

中文名称
——
中文别名
——
英文名称
3-(2-chloro-10H-phenothiazin-10-yl)propan-1-amine hydrochloride
英文别名
10H-Phenothiazine-10-propanamine, 2-chloro-, monohydrochloride;3-(2-chlorophenothiazin-10-yl)propan-1-amine;hydrochloride
3-(2-chloro-10H-phenothiazin-10-yl)propan-1-amine hydrochloride化学式
CAS
3763-80-2
化学式
C15H15ClN2S*ClH
mdl
——
分子量
327.277
InChiKey
CLFAUWZDUIVBAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    233-235 °C(Solv: ethanol (64-17-5))
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    4.71
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    54.6
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934300000

SDS

SDS:f4f3161509790aee677b584469f5ecbd
查看

反应信息

  • 作为反应物:
    描述:
    3-(2-chloro-10H-phenothiazin-10-yl)propan-1-amine hydrochloridesodium acetate 作用下, 以 氯仿溶剂黄146 为溶剂, 反应 1.75h, 生成 N-[3-(2-chloro-phenothiazin-10-yl)-propyl]-N-(toluene-4-sulfonyl)-acetamide
    参考文献:
    名称:
    nor1-和nor2-chloropromazine衍生物的合成。
    摘要:
    DOI:
    10.1002/jps.2600580235
  • 作为产物:
    描述:
    2-氯吩噻嗪盐酸 、 sodium hydride 、 作用下, 以 1,4-二氧六环乙醇N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 生成 3-(2-chloro-10H-phenothiazin-10-yl)propan-1-amine hydrochloride
    参考文献:
    名称:
    Reengineered tricyclic anti-cancer agents
    摘要:
    The phenothiazine and dibenzazepine tricyclics are potent neurotropic drugs with a documented but underutilized anti-cancer side effect. Reengineering these agents (TFP, CPZ, CIP) by replacing the basic amine with a neutral polar functional group (e.g., RTC-1, RTC-2) abrogated their CNS effects as demonstrated by in vitro pharmacological assays and in vivo behavioral models. Further optimization generated several phenothiazines and dibenzazepines with improved anti-cancer potency, exemplified by RTC-5. This new lead demonstrated efficacy against a xenograft model of an EGFR driven cancer without the neurotropic effects exhibited by the parent molecules. Its effects were attributed to concomitant negative regulation of PI3K-AKT and RAS-ERK signaling. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.07.007
点击查看最新优质反应信息

文献信息

  • Investigation of metabolite-protein interactions by transient absorption spectroscopy and in silico methods
    作者:Daniel Limones-Herrero、Fabrizio Palumbo、Victoria Vendrell-Criado、Inmaculada Andreu、Emilio Lence、Concepción González-Bello、Miguel A. Miranda、M. Consuelo Jiménez
    DOI:10.1016/j.saa.2019.117652
    日期:2020.2
    ligand exhibited higher ΔAmax values measured after the laser pulse and were also considerably longer-lived than the non-complexed forms. This is in agreement with an enhanced hydrophilicity of the metabolites, due to the replacement of methyl groups with H that led to a lower extent of protein binding. For the three compounds, laser flash photolysis displacement experiments using warfarin or ibuprofen
    瞬态吸收光谱结合计算机方法已用于研究人血清白蛋白(HSA)与抗精神病药氯丙嗪(CPZ)及其两种脱甲基代谢产物(MCPZ和DCPZ)之间的相互作用。因此,将含有CPZ,MCPZ或DCPZ和HSA(摩尔配体:蛋白质比例为1:0和1:3)的溶液进行激光闪光光解,对应于三重激发态的λ= 470 nm处的ΔAmax为。被监视。在所有情况下,与蛋白质结合的配体在激光脉冲后均显示出较高的ΔAmax值,并且比非复合形式的寿命更长。这与代谢物的亲水性增强相一致,这是由于用H取代了甲基导致了较低程度的蛋白质结合。对于这三种化合物,使用华法令或布洛芬的激光闪光光解置换实验表明,Sudlow位点I为主要结合位点。对接和分子动力学模拟研究表明,两个脱甲基配体与HSA的结合方式将与CPZ显着不同,特别是对于DCPZ,这似乎是由于它们的末端铵基团与氢负键稳定氢键相互作用的能力不同蛋白质袋(Glu153,Glu292)中
  • Synthesis of deuterium-labelled chlorpromazine and chlorpromazine metabolites
    作者:J. Cymerman Craig、L. D. Gruenke、S.-Y. Catherine Lee
    DOI:10.1002/jlcr.2580150106
    日期:1978.10
    The synthesis of 2-chloro-10-(3′-dimethylaminopropyl)phenothiazine-3′, 3′-d2 (Chlorpromazine-d2) and its four major metabolites (the mono- and didemethylated amines, chlorpromazine sulfoxide, and chlorpromazine N-oxide), all containing the 3′, 3′-d2 label in > 95% isotopic purity, is described. Considerations leading to the optimum number and position of the labels are discussed, and the problem of
    2-氯-10-(3'-二甲氨基丙基)吩噻嗪-3', 3'-d2 (Chlorpromazine-d2) 及其四种主要代谢物(单和二去甲基胺、氯丙嗪亚砜和氯丙嗪 N-氧化物)的合成),描述了所有的 3', 3'-d2 标记,同位素纯度 > 95%。讨论了导致最佳标记数量和位置的考虑因素,并通过利用现成的 2-氯-10-(2'-氰乙基)吩噻嗪作为起始原料,避免了将脂肪族侧链与三环系统偶联的问题材料,因此在引入同位素之前,侧链的碳骨架已经就位。
  • TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
    申请人:Ohlmeyer Michael
    公开号:US20140213578A1
    公开(公告)日:2014-07-31
    Tricyclic chemical modulators of FOXO transcription factor proteins are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazine, dibenzoazepine and annulene and similar genera:
    本文披露了三环化学调节剂对FOXO转录因子蛋白的调节作用。这些化合物可用于治疗癌症、年龄相关蛋白质毒性、压力引起的抑郁症、炎症和痤疮。这些化合物属于以下苯硫噻嗪、二苯并氮杂环和环戊烯类似物系列:
  • [EN] TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS<br/>[FR] COMPOSÉS TRICYCLIQUES EN TANT QU'AGENTS ANTICANCÉREUX
    申请人:MT SINAI SCHOOL OF MEDICINE
    公开号:WO2013025882A3
    公开(公告)日:2013-04-25
  • The Preparation of Some Derivatives of β-(10-Phenothiazinyl)propionic Acid and β-(2-Chloro-10-phenothiazinyl)propionic Acid
    作者:ERIK F. GODEFROI、EUGENE L. WITTLE
    DOI:10.1021/jo01116a027
    日期:1956.10
查看更多